Progesterone is one of the most important hormones in reproduction — and one of the most misunderstood. Patients in fertility treatment are often told their progesterone is "being watched" without a clear explanation of what values are expected, why supplementation is given, or why a declining progesterone in early pregnancy doesn't always mean the pregnancy is failing.
This guide demystifies progesterone: what it does in a natural cycle, what levels to expect at each stage, how supplementation works in IVF and frozen embryo transfer, and how to interpret progesterone readings during early pregnancy.
What Does Progesterone Do?
Progesterone is a steroid hormone produced primarily by the corpus luteum — the structure that forms in the ovary after an egg is released at ovulation. Its key reproductive functions include:
- Uterine lining transformation: After ovulation, progesterone converts the thickened, estrogen-primed endometrium from a proliferative state to a secretory state — rich in glycogen and other nutrients that support an embryo
- Implantation window regulation: Progesterone controls the timing of the implantation window, the brief period (typically days 6–10 after ovulation) when the endometrium is receptive to a blastocyst
- Cervical mucus thickening: Post-ovulation progesterone makes cervical mucus thick and impenetrable — preventing additional sperm entry and creating a protective barrier
- Suppression of uterine contractions: Progesterone relaxes the myometrium, reducing contractions that could disrupt implantation or an early pregnancy
- Early pregnancy support: Until the placenta takes over (around weeks 8–10), the corpus luteum is the sole source of progesterone for the developing pregnancy
Progesterone in the Natural Menstrual Cycle
Understanding progesterone levels in a natural ovulatory cycle provides the baseline for interpreting all other clinical scenarios.
| Cycle Phase | Typical Progesterone Level |
|---|---|
| Follicular phase (days 1–13) | <1 ng/mL |
| Pre-ovulatory (LH surge) | 1–2 ng/mL (brief rise triggers ovulation) |
| Early luteal phase (days 15–18) | 2–10 ng/mL |
| Mid-luteal phase (days 19–22) | 10–20+ ng/mL (peak) |
| Late luteal phase (days 23–26) | Declining toward 1 ng/mL |
| If pregnancy occurs | Rising; should double roughly every 2–3 days early on |
| If no pregnancy | Drops to <1 ng/mL; triggers menstruation |
Mid-Luteal Progesterone and Ovulation Confirmation
The mid-luteal progesterone draw — done approximately 7 days after suspected ovulation (day 21 in a 28-day cycle, or 7 days post-LH surge in irregular cycles) — is the standard test to confirm that ovulation occurred.
| Mid-Luteal Progesterone | Interpretation |
|---|---|
| >10 ng/mL | Strong evidence of ovulation |
| 3–10 ng/mL | Possible ovulation; luteal phase may be inadequate |
| <3 ng/mL | Anovulation likely — no ovulation occurred |
A value above 10 ng/mL confirms that the corpus luteum formed and is secreting normally. Values of 3–10 ng/mL are in a gray zone — ovulation may have occurred but with suboptimal corpus luteum function.
Luteal Phase Deficiency: Real or Controversial?
Luteal phase deficiency (LPD) — defined as insufficient progesterone production after ovulation — has been debated in reproductive medicine for decades. The concept is biologically plausible: if the corpus luteum doesn't make enough progesterone, the uterine lining may not become adequately receptive, and implantation or early pregnancy maintenance may fail.
However, the clinical diagnosis is difficult to standardize. A single low mid-luteal progesterone result may reflect:
- Normal cycle variation (progesterone secretion is pulsatile — levels fluctuate significantly within hours)
- Sampling timing error (draw done too early or too late in the luteal phase)
- True luteal insufficiency
The ASRM's committee opinion notes that LPD is poorly defined and that no single progesterone threshold reliably diagnoses it. Serial progesterone measurements or endometrial biopsy (dated histology) are more informative, though biopsy has largely fallen out of routine clinical use.
Empirical progesterone supplementation in the luteal phase for women with recurrent early pregnancy loss or unexplained infertility is commonly practiced, though evidence from large RCTs (including the PROMISE trial) has been mixed.
Trying to Conceive at Home?
Tracking your LH surge accurately helps time insemination in your fertility window — which is the same window when progesterone begins to rise after ovulation.
MakeAMom makes reusable at-home insemination kits in three designs: the CryoBaby for frozen or low-volume sperm, the Impregnator for low-motility sperm, and the BabyMaker for those with sensitivities. All ship discreetly and cost far less than a clinical IUI cycle.
Explore home insemination kits at MakeAMom →
Progesterone in IVF: Why Supplementation Is Required
In a standard IVF cycle, the ovarian stimulation protocol — particularly the use of a GnRH agonist or antagonist to prevent premature ovulation — suppresses the pituitary and disrupts the normal hormonal signaling that maintains corpus luteum function after egg retrieval.
After egg retrieval, the follicles that would normally develop into a corpus luteum are disrupted. Without external progesterone supplementation, the uterine lining would not maintain the secretory state needed for embryo transfer and implantation. Luteal phase progesterone support is therefore mandatory in virtually all IVF cycles.
Forms of Progesterone Supplementation in IVF
| Route | Common Products | Notes |
|---|---|---|
| Intramuscular (IM) injection | Progesterone in oil (sesame or olive oil) | High systemic absorption; injection site discomfort, lumps common |
| Vaginal suppository/gel | Endometrin, Crinone 8%, Prometrium (off-label) | Local uterine effect; lower serum levels than IM |
| Subcutaneous injection | Prolutex (progesterone aqueous) | Easier than IM; comparable efficacy in RCTs |
| Oral (micronized) | Prometrium | Mostly metabolized before systemic effect; not used as primary luteal support |
| Combined vaginal + IM | — | Used in high-risk cases (prior luteal phase failure) |
Multiple RCTs have compared vaginal to IM progesterone in IVF and found equivalent live birth rates in most patient populations. The choice between routes is typically based on patient preference, tolerance, and clinic protocol. Some evidence suggests IM progesterone may be preferred for women with prior IVF failures or those using donor eggs.
Devroey et al. (BJOG, 2009) established that vaginal progesterone (Crinone 8%) produces adequate endometrial progesterone levels even when serum levels appear lower than with IM injection — due to direct uterine absorption (the "first uterine pass effect").
Progesterone Thresholds in Frozen Embryo Transfer (FET)
Frozen embryo transfer (FET) cycles using exogenous hormones (estrogen + progesterone) give the reproductive endocrinologist precise control over the timing of the implantation window. Progesterone levels are checked on the day of transfer (or 1–2 days before) to confirm adequate lining preparation.
Serum Progesterone on the Day of FET
Recent evidence has established that serum progesterone level on the day of FET is predictive of outcomes — and this has changed clinical practice significantly.
| Serum Progesterone on FET Day | Interpretation |
|---|---|
| <10 ng/mL | Insufficient — associated with higher implantation failure rates; consider delaying or supplementing |
| 10–20 ng/mL | Adequate for most patients |
| >20 ng/mL | Good levels with vaginal-only protocols — use IM if vaginal gives <10 |
Devroey and colleagues, along with subsequent studies from ESHRE-affiliated centers, showed that serum progesterone <10 ng/mL on the day of transfer in medicated FET cycles was associated with a significantly lower clinical pregnancy rate and live birth rate compared to women with progesterone >10 ng/mL.
This finding has led many clinics to:
- Check serum progesterone on the day of or day before FET
- Supplement with additional vaginal progesterone or switch to IM injections when levels are below threshold
- Delay the transfer if progesterone is inadequate and repeat after dose adjustment
It is important to note that the threshold varies depending on the route of administration:
- Vaginal progesterone: serum levels of 8–15 ng/mL are typical and may be adequate
- IM progesterone: serum levels of 15–40 ng/mL are common and generally considered adequate
When in doubt, your clinic will guide you based on their specific protocol and the assay they use.
Progesterone in Early Pregnancy: What to Expect
Normal First-Trimester Progesterone Levels
In a natural conception, the corpus luteum continues to produce progesterone until the placenta takes over at approximately 8–10 weeks gestation. During this time:
| Gestational Age | Expected Progesterone |
|---|---|
| 4–5 weeks | 10–30 ng/mL |
| 6–7 weeks | 15–50 ng/mL |
| 8–10 weeks | 25–90 ng/mL |
| After 10–12 weeks | Rises further as placenta takes over; corpus luteum wanes |
Progesterone values in first-trimester IVF pregnancies are typically higher than natural conceptions because of exogenous supplementation — often 30–80 ng/mL or higher.
Does Falling Progesterone Mean Miscarriage?
One of the most anxiety-inducing situations in early pregnancy monitoring is a declining progesterone level. The important clinical distinction:
- Falling progesterone IS NOT the cause of most miscarriages. Chromosomally abnormal embryos fail to produce adequate HCG to maintain corpus luteum function — so progesterone drops as a result of the pregnancy failing, not the other way around.
- A single low progesterone in isolation does not diagnose miscarriage; it must be interpreted with HCG trend and ultrasound findings
- Declining progesterone with rising HCG and visible cardiac activity is generally reassuring — the pregnancy is progressing
The ASRM practice guideline notes that routine progesterone monitoring in asymptomatic first-trimester pregnancies (with normal HCG trends and ultrasound) is of limited clinical value and can cause unnecessary anxiety. If you are also tracking your ovarian reserve, reviewing how AMH and antral follicle count relate to your treatment planning will provide helpful context.
However, progesterone monitoring has value in specific circumstances:
- Women with prior pregnancy losses and known luteal phase concerns
- IVF pregnancies where supplementation is being tapered
- Bleeding or threatened miscarriage symptoms
- Singleton pregnancies conceived with donor eggs (where corpus luteum support is entirely exogenous)
What Low Progesterone in Pregnancy Might Mean
| Scenario | Interpretation |
|---|---|
| Low P4 + declining HCG | Pregnancy failing; probable miscarriage |
| Low P4 + normal rising HCG | May be corpus luteum insufficiency; consider supplementation |
| Low P4 + ectopic location on ultrasound | Risk of ectopic pregnancy — urgent evaluation needed |
| Low P4 in IVF pregnancy on supplementation | Check timing and dosing; consider increasing supplementation |
A progesterone value below 5 ng/mL in the first trimester is generally associated with non-viable pregnancy, though exceptions exist (particularly with frozen donor egg pregnancies where serum levels may be artificially suppressed while intrauterine levels are adequate).
Stopping Progesterone Support After IVF
One of the most common patient concerns in IVF is when to stop progesterone supplementation. Stopping too early — before the placenta is fully established — can theoretically disrupt progesterone supply.
Most clinics discontinue luteal progesterone support at 8–10 weeks of pregnancy, once:
- HCG is rising appropriately
- Cardiac activity is confirmed on ultrasound
- The placenta has taken over progesterone production
Some clinics taper supplementation gradually rather than stopping abruptly. Abrupt discontinuation at 8–10 weeks is generally safe — the placenta at this stage is producing progesterone independently.
Women with history of recurrent miscarriage or those using donor eggs (no corpus luteum at all) may be supplemented longer — up to 12 weeks — with the support of their physician.
Key Takeaways
- Mid-luteal progesterone >10 ng/mL confirms ovulation; <3 ng/mL suggests anovulation
- Luteal phase deficiency is clinically debated — isolated low readings may reflect pulsatile variation rather than true deficiency
- All IVF cycles require exogenous progesterone supplementation; vaginal and IM routes have equivalent live birth rates in most patients
- FET serum progesterone on transfer day matters — values <10 ng/mL are associated with lower success rates
- Falling progesterone in early pregnancy is usually a consequence of pregnancy failure, not the cause
- Most IVF programs discontinue progesterone support at 8–10 weeks once the placenta is established
Frequently Asked Questions
Q: What progesterone level confirms ovulation occurred? A: A mid-luteal progesterone level drawn approximately 7 days after suspected ovulation (day 21 in a 28-day cycle) above 10 ng/mL is strong evidence that ovulation occurred and the corpus luteum is secreting normally. Values of 3–10 ng/mL are a gray zone — ovulation may have occurred with suboptimal corpus luteum function. Values below 3 ng/mL suggest anovulation.
Q: Why is progesterone supplementation required after IVF? A: During IVF, the GnRH agonist or antagonist used to prevent premature ovulation also suppresses the pituitary and disrupts the hormonal signaling that normally maintains corpus luteum function after egg retrieval. Without this signaling, the corpus luteum cannot maintain the secretory endometrium needed for implantation. Exogenous progesterone supplementation is therefore mandatory in virtually all IVF cycles, regardless of the route used.
Q: Is vaginal progesterone as effective as intramuscular injections for IVF? A: Multiple randomized controlled trials have found equivalent live birth rates between vaginal and intramuscular progesterone in most patient populations. Vaginal progesterone achieves high local uterine concentrations due to direct absorption (the "first uterine pass effect"), even when serum levels appear lower than with IM injection. Many clinics now use vaginal progesterone as first-line, reserving IM injections for patients with specific indications.
Q: Does falling progesterone in early pregnancy cause miscarriage? A: In most cases, no — falling progesterone is a consequence of pregnancy failure rather than the cause. Chromosomally abnormal embryos fail to produce adequate hCG to maintain corpus luteum function, so progesterone drops as the pregnancy fails. A single low progesterone reading in isolation cannot diagnose miscarriage; it must be interpreted with hCG trend and ultrasound findings.
Q: When should progesterone supplementation stop after a successful IVF pregnancy? A: Most clinics discontinue progesterone support at 8–10 weeks of pregnancy, once hCG is rising appropriately, cardiac activity is confirmed on ultrasound, and the placenta has taken over progesterone production. Women with a history of recurrent miscarriage or those using donor eggs (with no corpus luteum) may be supplemented until 12 weeks. Stopping at 8–10 weeks is generally safe — abrupt discontinuation at this stage does not compromise the pregnancy.
References
- American Society for Reproductive Medicine (ASRM). Progesterone supplementation during the luteal phase and in early pregnancy in the setting of in vitro fertilization: an educational bulletin. Fertil Steril. 2008;89(4):789–792.
- Devroey P, Polyzos NP, Blockeel C. An OHSS-free clinic by segmentation of IVF treatment. Hum Reprod. 2011;26(10):2593–2597.
- Kyrou D, Fatemi HM, Zepiridis L, et al. Does cessation of progesterone supplementation during early pregnancy affect on going pregnancies? Eur J Obstet Gynecol Reprod Biol. 2011;157(1):45–48.
- van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2015;(7):CD009154.
- Labarta E, Mariani G, Paolelli S, et al. Impact of low serum progesterone levels on the day of embryo transfer on pregnancy outcome: a prospective cohort study in oocyte donation cycles. Hum Reprod. 2021;36(3):683–692.
This article is for informational purposes only and does not constitute medical advice. Consult a board-certified reproductive endocrinologist for guidance on progesterone monitoring and supplementation in your specific situation.




